Ligand Partner Receives Orphan Drug Designation By: TalkMarkets January 09, 2015 at 11:32 AM EST With the Orphan Drug designation for Sparsentan, Ligand should improve its long-term growth prospects. Read More >> Related Stocks: Ligand Pharm